| EULAR/ERA-EDTA recommendations for the management of ANCA-associated vasculitis M Yates, RA Watts, IM Bajema, MC Cid, B Crestani, T Hauser, B Hellmich, ... Annals of the rheumatic diseases 75 (9), 1583-1594, 2016 | 1452 | 2016 |
| EULAR recommendations for the management of primary small and medium vessel vasculitis C Mukhtyar, L Guillevin, MC Cid, B Dasgupta, K de Groot, W Gross, ... Annals of the rheumatic diseases 68 (3), 310-317, 2009 | 1315 | 2009 |
| Modification and validation of the Birmingham Vasculitis Activity Score (version 3) C Mukhtyar, R Lee, D Brown, D Carruthers, B Dasgupta, S Dubey, ... Annals of the rheumatic diseases 68 (12), 1827-1832, 2009 | 1244 | 2009 |
| 2018 Update of the EULAR recommendations for the management of large vessel vasculitis B Hellmich, A Agueda, S Monti, F Buttgereit, H De Boysson, E Brouwer, ... Annals of the rheumatic diseases 79 (1), 19-30, 2020 | 1098 | 2020 |
| Long-term patient survival in ANCA-associated vasculitis O Flossmann, A Berden, K de Groot, C Hagen, L Harper, C Heijl, ... Annals of the rheumatic diseases 70 (3), 488-494, 2011 | 1035 | 2011 |
| EULAR recommendations for the management of large vessel vasculitis C Mukhtyar, L Guillevin, MC Cid, B Dasgupta, K de Groot, W Gross, ... Annals of the rheumatic diseases 68 (3), 318-323, 2009 | 851 | 2009 |
| Outcomes from studies of antineutrophil cytoplasm antibody associated vasculitis: a systematic review by the European League Against Rheumatism systemic vasculitis task force C Mukhtyar, O Flossmann, B Hellmich, P Bacon, M Cid, ... Annals of the rheumatic diseases 67 (7), 1004-1010, 2008 | 529 | 2008 |
| EULAR recommendations for the management of systemic lupus erythematosus: 2023 update A Fanouriakis, M Kostopoulou, J Andersen, M Aringer, L Arnaud, SC Bae, ... Annals of the rheumatic diseases 83 (1), 15-29, 2024 | 436 | 2024 |
| EULAR recommendations for the management of ANCA-associated vasculitis: 2022 update B Hellmich, B Sanchez-Alamo, JH Schirmer, A Berti, D Blockmans, ... Annals of the Rheumatic Diseases 83 (1), 30-47, 2024 | 385 | 2024 |
| EULAR recommendations for cardiovascular risk management in rheumatic and musculoskeletal diseases, including systemic lupus erythematosus and antiphospholipid syndrome GC Drosos, D Vedder, E Houben, L Boekel, F Atzeni, S Badreh, ... Annals of the rheumatic diseases 81 (6), 768-779, 2022 | 308 | 2022 |
| British Society for Rheumatology guideline on diagnosis and treatment of giant cell arteritis SL Mackie, C Dejaco, S Appenzeller, D Camellino, C Duftner, ... Rheumatology 59 (3), e1-e23, 2020 | 285 | 2020 |
| Definitions and reliability assessment of elementary ultrasound lesions in giant cell arteritis: a study from the OMERACT Large Vessel Vasculitis Ultrasound Working Group S Chrysidis, C Duftner, C Dejaco, VS Schäfer, S Ramiro, G Carrara, ... RMD open 4 (1), e000598, 2018 | 239 | 2018 |
| A model to predict cardiovascular events in patients with newly diagnosed Wegener's granulomatosis and microscopic polyangiitis R Suppiah, A Judge, R Batra, O Flossmann, L Harper, P Höglund, ... Arthritis care & research 63 (4), 588-596, 2011 | 200 | 2011 |
| A cross-sectional study of the Birmingham Vasculitis Activity Score version 3 in systemic vasculitis R Suppiah, C Mukhtyar, O Flossmann, F Alberici, B Baslund, R Batra, ... Rheumatology 50 (5), 899-905, 2011 | 147 | 2011 |
| Evidence-Based Guideline for the diagnosis and management of eosinophilic granulomatosis with polyangiitis G Emmi, A Bettiol, E Gelain, IM Bajema, A Berti, S Burns, MC Cid, ... Nature reviews Rheumatology 19 (6), 378-393, 2023 | 138 | 2023 |
| 2022 EULAR points to consider for remote care in rheumatic and musculoskeletal diseases A De Thurah, P Bosch, A Marques, Y Meissner, CB Mukhtyar, J Knitza, ... Annals of the rheumatic diseases 81 (8), 1065-1071, 2022 | 115 | 2022 |
| Health‐related quality of life in patients with newly diagnosed antineutrophil cytoplasmic antibody–associated vasculitis M Walsh, C Mukhtyar, A Mahr, K Herlyn, R Luqmani, PA Merkel, ... Arthritis care & research 63 (7), 1055-1061, 2011 | 95 | 2011 |
| Current state of tumour necrosis factor α blockade in Wegener’s granulomatosis C Mukhtyar, R Luqmani Annals of the rheumatic diseases 64 (suppl 4), iv31-iv36, 2005 | 91 | 2005 |
| Assessing vasculitis in giant cell arteritis by ultrasound: results of OMERACT patient-based reliability exercises VS Schäfer, S Chrysidis, C Dejaco, C Duftner, A Iagnocco, GA Bruyn, ... The Journal of rheumatology 45 (9), 1289-1295, 2018 | 69 | 2018 |
| Measurement of damage in systemic vasculitis: a comparison of the Vasculitis Damage Index with the Combined Damage Assessment Index R Suppiah, O Flossman, C Mukhtyar, F Alberici, B Baslund, D Brown, ... Annals of the rheumatic diseases 70 (1), 80-85, 2011 | 68 | 2011 |
David JayneProfessor of Clinical Autoimmunity, University of CambridgeVerificeret mail på cam.ac.uk
